Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21271613

Download in:

View as

General Info

PMID
21271613